Paying users zone. Data is covered by .

  • Get to Abbott Laboratories for $17.99, or

  • get to whole website for at least 3 months from $49.99.



Statement of Cash Flows

Difficulty: Beginner

The cash flow statement provides information about a company's cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company's statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Abbott Laboratories, Consolidated Statement of Cash Flows

USD $ in millions

12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net earnings
Amortization of intangible assets
Share-based compensation
Impact of currency devaluation
Amortization of inventory step-up
Investing and financing (gains) losses, net
Amortization of bridge financing fees
Net loss on extinguishment of debt
Gains on sale of businesses
Mylan N.V. equity investment adjustment
Gain on sale of Mylan N.V. shares
Trade receivables
Prepaid expenses and other assets
Trade accounts payable and other liabilities
Income taxes
(Increase) decrease in operating capital
Adjustments to reconcile earnings to net cash from operating activities
Net cash from operating activities
Acquisitions of property and equipment
Acquisitions of businesses and technologies, net of cash acquired
Proceeds from business dispositions
Proceeds from the sale of Mylan N.V. shares
Purchases of investment securities
Proceeds from sales of investment securities
Net cash (used in) from investing activities
Proceeds from issuance (repayments) of short-term debt and other
Proceeds from issuance of long-term debt and debt with maturities over 3 months
Repayments of long-term debt and debt with maturities over 3 months
Payment of bridge financing fees
Purchase of Alere preferred stock
Acquisition and contingent consideration payments related to business acquisitions
Transfer of cash and cash equivalents to AbbVie Inc.
Purchases of common shares
Proceeds from stock options exercised
Dividends paid
Net cash from (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Source: Abbott Laboratories, Annual Reports
Item Description The company
Net cash from operating activities The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. Abbott Laboratories's net cash from operating activities increased from 2015 to 2016 and from 2016 to 2017.